Navigation Links
Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
Date:12/9/2011

LOS ANGELES, Dec. 9, 2011 /PRNewswire/ -- Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from ongoing Phase II clinical trials of Puma's investigational drug PB272 (neratinib) were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium that is currently taking place in San Antonio, Texas.  These presentations are further detailed below:

Safety and Efficacy of Neratinib in Combination With Capecitabine in Patients With ErbB2-positive Breast Cancer

The Phase I/II clinical trial of PB272 given in combination with the chemotherapy drug capecitabine was conducted at numerous locations in the United States, Europe and Asia.  The trial was sponsored by Pfizer and the Phase I results of this trial were previously presented last year.  The Phase II portion of the study, presented at this symposium, enrolled patients with confirmed ErbB2+ (HER2+) metastatic or locally advanced breast cancer, and documented disease progression following prior treatment with trastuzumab and taxane chemotherapy.  Patients were administered PB272 at a dose of 240 mg per day in combination with capecitabine given at a dose of 1,500 mg/m2 (750 mg/m2 twice daily) on Days 1 to 14 of each 21-day cycle.

The results of the study showed that the combination of PB272 and capecitabine had acceptable tolerability.  The most frequently observed severe adverse event in the trial was diarrhea with 26% of the patients experiencing grade 3/4 diarrhea.  The diarrhea was reported to be transient and managed with antidiarrheal agents and dose modifications.  The efficacy results from the trial showed that for the 61 patients in the trial who had not been previously treated with the HER2 targeted agent lapatinib, 7 (11%) patients experienced a complete response, 32 (52%) patients experienced a partial response and 5 (8%) patients experienced stable disease for greater than 6 mo
'/>"/>

SOURCE Puma Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
2. Animal Biotechnology - Technologies, Markets and Companies
3. Puma Biotechnology Announces Completion of Private Placement
4. HUYA Bioscience International Builds Long-Term Relationship with Shenzhen Polytechnic School of Applied Chemistry and Biotechnology
5. Congressman Eric Cantor and Health Diagnostic Laboratory, Inc. Discuss Job Growth at Virginia BioTechnology Research Park
6. Industrial Biotechnology China News 1109 - Annual Subscription
7. Nanobiotechnology: Applications and Global Markets
8. Californias Industrial Biotechnology Workforce: Creating Jobs and Leading Innovation
9. Global Biotechnology Instrumentation Industry
10. Separation Systems for Commercial Biotechnology
11. TWi Biotechnology Successfully Completes Patient Recruitment for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- Technology Applications International Corporation (the "Company" or "NUUU")(OTC BB: ... Inc. has signed an additional exclusive licensing agreement with ... Johnson Space Center in Houston , ... Charles J. Scimeca , NUUU,s ... latest, exclusive agreement with NASA. In addition to our ...
(Date:9/2/2014)... 2, 2014  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, ... the appointment of Debra Zack , M.D., ... of Lloyd Rowland , senior vice president, ... "Debra,s expertise in biologics clinical development and ...
(Date:9/2/2014)... 02, 2014 PMG Research, Inc ... clinical research site: PMG Research of Rocky Mount. Effective ... of the clinical research department at Boice-Willis Clinic ... in eastern North Carolina. This new site enhances PMG’s ... in Rocky Mount and the surrounding communities, this brings ...
(Date:9/1/2014)... Sept. 1, 2014 Reportlinker.com announces that ... its catalogue: India Solid Waste Management ... http://www.reportlinker.com/p02350445/India-Solid-Waste-Management-Vehicles-Market-Forecast-and-Opportunities-2019.html In ... main governing bodies responsible for complete handling and ... an average, around 135,000 MT solid waste is ...
Breaking Biology Technology:Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 2India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 3India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 4India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 5India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 6India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 7India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 8
... , NEW YORK, Aug. 13 Cadus Corporation (OTC ... 30, 2009. , , Revenues were $0 for the second ... for the second quarter of 2009 was $103,330, compared to net income of ... for the second quarter of 2009 was $0.01, compared to basic net income ...
... , , , , ... ABT ) today announced the expansion of the company,s XIENCE ... of the company,s market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System ... allows for more than 2,000 patients from the XIENCE V USA ...
... 13 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc., (TSX: SDI), a ... a therapeutic targeting severe sepsis, today announced its financial ... , "During the quarter, results of the EUPHAS trial ... Medical Association (JAMA). The findings showed that the Toraymyxin(TM) ...
Cached Biology Technology:Cadus Reports Second Quarter 2009 Results 2Cadus Reports Second Quarter 2009 Results 3Cadus Reports Second Quarter 2009 Results 4Cadus Reports Second Quarter 2009 Results 5Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial 2Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial 3Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial 4Spectral announces second quarter 2009 results 2Spectral announces second quarter 2009 results 3Spectral announces second quarter 2009 results 4Spectral announces second quarter 2009 results 5Spectral announces second quarter 2009 results 6Spectral announces second quarter 2009 results 7Spectral announces second quarter 2009 results 8
(Date:9/2/2014)... take stress in stride; others are done in by ... molecular mechanisms of this so-called stress gap in mice ... could lead researchers to better understand the development of ... people, each animal has unique experiences as it goes ... experiences can alter the expression of genes, and as ...
(Date:9/1/2014)... the U.S. has improved steadily in recent yearsspurred in ... quality remains poor and disparities continue to widen among ... from Harvard School of Public Health (HSPH). , "The ... the extensive efforts by many groups and individuals to ... it also indicates that these efforts need to be ...
(Date:9/1/2014)... Conventional wisdom has long held that corals ... reefs are passive organisms that rely entirely ... as nutrients and oxygen. But now scientists at ... in Israel have found that they are far ... into turbulent patterns that greatly enhance their ability ...
Breaking Biology News(10 mins):Discovery hints at why stress is more devastating for some 2Discovery hints at why stress is more devastating for some 3Quality of US diet shows modest improvement, but overall remains poor 2Quality of US diet shows modest improvement, but overall remains poor 3Nature's tiny engineers 2Nature's tiny engineers 3
... to thwart persistent bacterial infections and better control ... artificial chemicals that infiltrate and sabotage bacterial "mobs." ... at the 229th national meeting of the American ... Blackwell described the ongoing construction of a new ...
... where you might find love these days. A team ... psychologist found love-related neurophysiological systems inside a magnetic resonance ... brains of 17 young men and women who each ... , The multidisciplinary team found that early, intense romantic ...
... Research Center have, for the first time, induced a ... the first demonstration of "hibernation on demand" in a ... cancer and prevent injury and death from insufficient blood ... essence, temporarily converting mice from warm-blooded to cold-blooded creatures, ...
Cached Biology News:To control germs, scientists deploy tiny agents provocateurs 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 3Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 4Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 5Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 6Buying Time Through Hibernation on Demand 2Buying Time Through Hibernation on Demand 3Buying Time Through Hibernation on Demand 4Buying Time Through Hibernation on Demand 5